ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 756469 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 756469; 2) Community: the network communities that were significantly associated with the response to NSC 756469; 3) Molecule: the relationships between components within communities and NSC 756469; 4) MDR: the compounds that were significantly associated with the NSC 756469.

NSC Compound Enrichment Correlation
NSC 716951 Null 0.0201565205286441 0.19188965
NSC 723732 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one 0.0201565205286441 -0.061810536
NSC 746053 Null 0.0201565205286441 0.017100075
NSC 294961 5-Bromo-3-(2-oxo-2-phenylethylidene)- 1,3-dihydroindol-2-one 0.0203119150246197 -0.030500726
NSC 331935 CHALCONE ANALOG 0.0203119150246197 0.19197937
NSC 639501 Cyclopentanone, 2-pentylidene-5-[(1-piperidinyl)methyl]- hydrochloride 0.0203119150246197 -0.038970895
NSC 661581 2-Azabicyclo[16.3.1]docosane, geldanamycin deriv. 0.0203119150246197 0.15232188
NSC 666034 Carquniostatin B 0.0203119150246197 0.090193188
NSC 756483 SB-742864 0.021946808377072 0.62657983
NSC 758670 TANNIC ACID 0.021946808377072 -0.15858609
Total:46  Current:21    [First] [Prev] [Next] [Last]